In an effort to combat opioid diversion in Medicare, the Senate and House introduced a number of bills that include a pharmacy lock-in provision. Pharmacy lock-in requires Medicare Part D beneficiaries to obtain their schedule II narcotics form a single, approved pharmacy; i.e., they are locked into that one pharmacy for their controlled drugs. These beneficiaries are permitted to get their non-controlled drugs from the pharmacy of their choosing, within their provider network.
CARA passed Congress during a quick conference committee vote in July and President Obama signed the bill into law shortly after congressional passage. ASCP retained the exemption from lock-in for long-term care, and are working to ensure implementation of this, and other provisions for partial fill in the community setting, do not affect practice in long-term post-acute settings.